NHS National Framework for Denosumab Injection commencing 1st January 2026
key details
| Value | £57,000,000 (£68,400,000 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, East Midlands, West Midlands, East of England, South East, South West, Yorkshire and the Humber, London |
| Deadline | 4 Sept 2025 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-05506a |
Awards (8)
This procurement was awarded to 8 suppliers. Values shown are per-award; the notice total is £57,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £37,694,000 | 29 Sept 2025 | active |
| Amgen Ltd shared | £15,059,000 | 29 Sept 2025 | active |
| Biosimilar Collaborations Ireland Limited shared | £37,694,000 | 29 Sept 2025 | active |
| Celltrion Healthcare United Kingdom Limited shared | £37,694,000 | 29 Sept 2025 | active |
| Fresenius Kabi Limited shared | £15,059,000 | 29 Sept 2025 | active |
| Gedeon Richter UK Ltd shared | £37,694,000 | 29 Sept 2025 | active |
| Teva UK Limited shared | £37,694,000 | 29 Sept 2025 | active |
| Zentiva Pharma UK Ltd shared | £37,694,000 | 29 Sept 2025 | active |
description
Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026
Offer reference number: CM/TNS/25/5725
Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
CM/TNS/25/5725/01 - Regional award for Denosumab Injection:
NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months)
SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months)
MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months)
LNW: (London) 01/01/2026 to 31/12/2026 (12 months)
CM/TNS/25/5725/02 - National award for Denosumab Injection:
7NAT (National) 01/01/2026 to 31/12/2026 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
NOTE: Please see Attached Contract Copy document for the list of Unsuccessful Suppliers.
documents
- https://www.find-tender.service.gov.uk/Notice/047020-2025 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-4117 , biddingDocuments
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 19 Jun 2025 | Preliminary market engagement (UK2) | Procurement Act 2023 | 033870-2025 |
| 7 Aug 2025 | Tender notice (UK4) | Procurement Act 2023 | 047020-2025 |
| 2 Oct 2025 | Contract award (UK6) | Procurement Act 2023 | 061522-2025 |
| 4 Dec 2025 | Contract details (UK7) | Procurement Act 2023 | 079939-2025 |
more from NHS England
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
- NHS National Framework for Ferric Carboxymaltose injection · £62,633,000 · 21 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.